Skip to content

CAVA 集团

US · CAVA #1881 按市值排名 上市于 2023
57.25 +1.85 +3.34%
实时 - 追踪5344个代码 - 心跳于502秒前 · 2026-10-16 19:57

最新新闻

  • Emyria Taps Former U.S. VA Secretary Shulkin to Bolster U.S. Psychedelic Strategy
    TipRanks · 2026/10/6
  • Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
    TipRanks · 2026/4/15
  • On Aug 20, Personalis Received A New Task Order Under Its Contract With U.S. Department Of Veterans Affairs For VA MVP; New Task Order Effective Sept 30, 2026, Valued Up To $18.30M
    Benzinga · 2026/8/21
  • Emyria Taps Former U.S. VA Secretary Shulkin to Drive U.S. Psychedelic Strategy
    TipRanks · 2026/9/21
  • 公司公告
    8-K: U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA
    SEC · 2025/9/4
  • Tactile Medical Enters Exclusive U.S. Distribution Agreement With ElastiMed for Its MyoSleeve Wearable Compression Device for VA and DoD Patients
    GlobeNewswire · 2026/7/13

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:57:42 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

CAVA 集团 讨论区 0 条评论

发表评论